Flonoltinib clinical trials
Includes 2 studies of Flonoltinib maleate.
How each study uses flonoltinib is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the flonoltinib studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
9 studies that test it; most in 2026 (4)
| Year | Studies |
|---|---|
| 2021 | 2 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 4 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 9 · Other 0
Chengdu Zenitar Biomedical Technology Co., Ltd (8) · Guizhou Bailing Group Pharmaceutical Co Ltd (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2
Studies that test flonoltinib.
- Dec 2026Clinical Study on Drug Interactions of Flonoltinib Maleate TabletsPhase 1 · Chengdu Zenitar Biomedical Technology Co., Ltd
- Jul 2027Phase IIa Study of Flonoltinib Maleate Tablets in the Treatment of Patients With Polycythemia VeraPhase 2 · Chengdu Zenitar Biomedical Technology Co., Ltd
Studies
Open first, then newest update. How each study uses flonoltinib is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 9
- Clinical Study on Drug Interactions of Flonoltinib Maleate TabletsNot yet recruitingPhase 1Chengdu Zenitar Biomedical Technology Co., LtdNCT07768111Written as 75mg Flonoltinib
- Phase IIa Study of Flonoltinib Maleate Tablets in the Treatment of Patients With Polycythemia VeraRecruitingPhase 2Chengdu Zenitar Biomedical Technology Co., LtdNCT07232290Written as Flonoltinib 75mg
- A Clinical Trial of Flonoltinib Maleate for Intermediate or High-Risk MyelofibrosisRecruitingPhase 3Chengdu Zenitar Biomedical Technology Co., LtdNCT07317700Written as Flonoltinib 75mg
- A Clinical Trial of Flonoltinib Maleate Tablets in the Treatment of JAK Inhibitor Refractory/Relapsed/Intolerant Patients With Intermediate to High Risk MyelofibrosisRecruitingPhase 2Chengdu Zenitar Biomedical Technology Co., LtdNCT07443306Written as Flonoltinib Maleate
- Mass Balance Study of [14C] Flonoltinib MaleateCompletedPhase 1Chengdu Zenitar Biomedical Technology Co., LtdNCT07612306Written as Flonoltinib 75mg
- Study of Flonoltinib Maleate Tablets in the Treatment of Proliferative Bone Marrow TumorsWithdrawnPhase 1Guizhou Bailing Group Pharmaceutical Co LtdNCT05115344Written as flonoltinib 25mg
- A Phase II Clinical Trial of Flonoltinib Maleate Tablet in Intermediate-High Risk MyelofibrosisActive, not recruitingPhase 2Chengdu Zenitar Biomedical Technology Co., LtdNCT06457425Written as Flonoltinib 50mg
- Safety of Flonoltinib Maleate Tablets for the Treatment of Patients With MyeloproliferativeCompletedPhase 1/2Chengdu Zenitar Biomedical Technology Co., LtdNCT05153343Written as flonoltinib 25mg
- A Phase I Clinical Study of Flonoltinib Maleate Tablets in Healthy SubjectsCompletedPhase 1Chengdu Zenitar Biomedical Technology Co., LtdNCT06387966Written as Flonoltinib Maleate Tablets